Sarcoidosis is a systemic disease of unknown etiology defined by the presence of
noncaseating granulomatous inflammation that can cause organ damage and diminished …

Sarcoidosis is a systemic inflammatory disease with substantial morbidity and increasing
mortality. As part of the National Heart, Lung, and Blood Institute's workshop to better …

Designing and Conducting Health Surveys is written for students, teachers, researchers, and
anyone who conducts health surveys. This third edition of the standard reference in the field …

Palliative care aims to prevent and relieve suffering by controlling symptoms and to provide
other support to patients and families in order to maintain and improve their quality of living …

Background: Depression is common after spinal cord injury (SCI), yet it can be difficult and
costly to diagnose. Screening tools such as the Center for Epidemiological Studies …

Background Glucocorticoids (GC) are considered first-line therapy for treating sarcoidosis,
but there are few data about the adverse consequences of GC. Although there are several …

Sarcoidosis is a chronic inflammatory disease of unknown etiology characterized by multi-
organ involvement. End-organ disease consists of granulomatous inflammation, which if left …

Background Long‐term corticosteroid therapy is the standard of care for treatment of cardiac
sarcoidosis (CS). The efficacy of long‐term corticosteroid‐sparing immunosuppression in …

Background: The 6-min walk test has proved useful in assessing impairment and prognosis
in various lung diseases. Methods: A prospective study of 142 sarcoidosis patients seen …

Sarcoidosis is a systemic granulomatous inflammatory disease of unknown etiology. It
affects the lungs in over 90% of patients yet extra-pulmonary and multi-organ involvement is …